IPSA
VC
INVESTOR TYPE
Active
STATUS
3
PROFESSIONALS
37
INVESTMENTS
6
PORTFOLIO
23
EXITS
Description
IPSA is an investment firm based in Paris, France and was founded in 1997. The firm specializes in seed, early stage, later stage and growth investments. The firm seeks to invest in life science, telecommunication, biotechnology, medical, energy, chemistry, information and communications technology, natural resources, cleantech, capital good and distribution sectors.
Website
Formerly Known As
Innoven Partenaires
Investor Status
Actively Seeking New Investments
Year Founded
1997
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Growth/Expansion
Primary Office
- 13-15, rue Taitbout
- 75009 Paris
- France
+33 01 00 00 00 00
IPSA Investments (37)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Symbio (hydrogen battery kits) | 07-May-2014 | Early Stage VC | Other Commercial Services | Generating Revenue | 000000 0000000 | |
| 000000 00000000 | 01-Jan-2012 | 0000 | Security Services (B2B) | Profitable | ||
| 0000000000 | 27-Sep-2011 | 00000 00000 | 00.00 | Medical Supplies | Profitable | 000000 0000000 |
| 00000000000 | 06-Jul-2011 | 00000 00000 | 000 | Medical Supplies | Generating Revenue | |
| 000000 (00000000 0 | 01-Dec-2010 | 00000 00000 | Other Commercial Services | Generating Revenue | 000000 0000000 | |
| 0000 00000 | 27-Oct-2010 | 00000 00000 | Social Content | Generating Revenue | ||
| 00000 | 26-Oct-2010 | 00000 00000 | 00000 | Laboratory Services (Healthcare) | Generating Revenue | |
| 0000000 0000000000 | 05-Jan-2010 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 000000 0000000 |
| BioVex Group | 10-Nov-2009 | Later Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 3 | |
| SpineGuard | 09-Apr-2009 | Early Stage VC | 0000 | Medical Supplies | Profitable | 000000 0000000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore IPSA’s full profile, request a free trial.
IPSA Exits (23)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Eyegate Pharmaceuticals | 17-May-2018 | Secondary Transaction - Open Market | Completed |
|
|
| 0000000 0000000000 | 12-Jun-2017 | 000000 0000000000 | 00.000 | Completed |
|
| 000 000000000 | 01-Feb-2017 | 000000000000000000 | 00000 | Completed |
|
| 00000000000 | 06-Sep-2016 | 000000000000000000 | Completed |
|
|
| 0000 | 27-Mar-2015 | 000000000000000000 | Completed |
|
|
| 0000000 0000000000 | 12-Feb-2015 | 000 | 00.00 | Completed |
|
| 0000000 (00000000) | 17-Dec-2014 | 000000000000000000 | 0000 | Completed |
|
| 00000 | 28-May-2014 | 000000000000000000 | 0000 | Completed |
|
| SpineGuard | 26-Apr-2013 | IPO | 000.00 | Completed |
|
| OctoPlus | 28-Feb-2013 | Merger/Acquisition | 000.00 | Completed |
IPSA Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore IPSA‘s full profile, request access.
Request full access to PitchBookIPSA Team (7)
4 Former Team Members
You’re viewing 3 of 7 team members. Get the full list »